Tango Therapeutics TNGX
NASDAQ TNGX
$24.45 -0.50 (-2.00%)
At close: Oct 1, 2026 · 4:00 PM EDT

Tango Therapeutics (TNGX) Return on Equity [ROE] (2021 - 2026)

Updated

Tango Therapeutics (TNGX) posted Return on Equity [ROE] of -17.47% for Q2 2026, up 79.00 percentage points from -96.47% a year earlier and up 11.59 percentage points from the prior quarter.

Analysis

Tango Therapeutics (TNGX) Return on Equity [ROE] (2021 - 2026) Analysis & Trends

For FY2025, Tango Therapeutics' Return on Equity [ROE] came in at -37.23%, up 20.34 percentage points from FY2024.

  • Annual Return on Equity [ROE] shows a four-year change of -6.85 percentage points (FY2021 to FY2025).
  • In prior years, Tango Therapeutics' Return on Equity [ROE] was -57.58% in FY2024 (-17.09 pp), -40.49% in FY2023 (-4.06 pp), -36.42% in FY2022 (-6.04 pp) and -30.39% in FY2021.
  • The Q2 2026 figure stands as the highest quarterly Return on Equity [ROE] since Q4 2021.
  • On a year-over-year basis, Return on Equity [ROE] has increased in each of the last three quarters, with an average year-over-year change of +1.65 percentage points over the last eight quarters.
  • The strongest year-over-year quarter for Return on Equity [ROE] in the past five years was Q2 2026, with a gain of 79.00 percentage points; the weakest was Q2 2025, with a drop of 50.98 percentage points.
  • According to Business Quant data, Return on Equity [ROE] for the three prior quarters was -29.06% (Q1 2026), -40.12% (Q4 2025) and -68.12% (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROE (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 25.32%
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn -
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 7.21%
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 84.40%
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 21.39%
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 83.75%
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn -18.38%
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 4.97%
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 22.24%
10 Tango Therapeutics 4.20 Bn 2.31 Bn - -17.47%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -17.47%
Mar 31, 2026 -29.06%
Dec 31, 2025 -40.12%
Sep 30, 2025 -68.12%
Jun 30, 2025 -96.47%
Mar 31, 2025 -72.20%
Dec 31, 2024 -60.77%
Sep 30, 2024 -51.75%
Jun 30, 2024 -45.49%
Mar 31, 2024 -43.15%
Dec 31, 2023 -38.42%
Sep 30, 2023 -40.90%
Jun 30, 2023 -48.57%
Mar 31, 2023 -46.58%
Dec 31, 2022 -41.42%
Sep 30, 2022 -35.39%
Jun 30, 2022 -29.63%
Mar 31, 2022 -20.33%
Dec 31, 2021 -15.35%
Sep 30, 2021 -19.66%
API Access

Tango Therapeutics Return on Equity [ROE] API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=return-on-equity-%5Broe%5D&ticker=TNGX&period=max&api_key=YOUR_API_KEY